why choose us

First received: July 25, 2022

Clinical Trial: ArtemiCoffee in Patients With Rising PSA

Study Status: Completed

Recruit Status: RECRUITING

Condition: Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: Phase II Trial of ArtemiCoffee for Men With Biochemical Recurrence of Prostate Cancer After Initial Local Therapy

Brief Summary: Until now, clinicians have been challenged to improve the treatment of biochemically recurrent (BCR) prostate cancer in which prostatic specific antigen (PSA) rises without radiological or clinical progression years after localized treatment (radical prostatectomy or radiation therapy) with or without hormonal treatment.Approximately 50-90% of men with high-risk prostate cancer will experience a BCR.Artesunate has demonstrated anti-tumor activity in both in vivo and in vitro cell lines.It is hypothesized that…

Read more